MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Lewy Pathology correlates with neuroinflammation in the hippocampus of Synucleinopathy patients in a subregion specific manner

E. Luna, K. Cousins, S. Emrani, K. Luk, V. Lee, E. Lee, D. Weintraub, S. Xie, A. Chen-Plotkin, F. Bennett, D. Irwin (Philadelphia, USA)

Meeting: 2025 International Congress

Keywords: Alpha-synuclein, Hippocampus, Inflammation

Category: Parkinson's Disease: Pathophysiology / molecular mechanisms of disease

Objective: The objective of this study is to examine the sub-regional differences in neuroinflammation (NI) in response to Lewy pathology (LP) within the hippocampus of autopsied Lewy body disease (LBD).

Background: LP is associated with an increase in NI derived from microglia (MG) but there is conflicting evidence to the role of MG in LBD pathogenesis. Progressive transsynaptic LP staging has been extensively studied in human autopsy tissue (i.e. Braak staging) but studies seldom account for neuroinflammation and often use sampling across multiple synaptic connections. Here we address these gaps in a focused digital histopathologic study of LP and NI within the human hippocampal subfields including cornu ammonis (CA) subfield 2 that is preferentially vulnerable to LP and the relatively spared dentate gyrus to test the hypothesis that NI within the hippocampus follows the same pattern of vulnerability to LP.

Method: We included autopsy-confirmed relatively pure LBD patients with limited age-related co-pathologies (n=68) and immunostained consecutive FFPE hippocampal sections for pathologic phosphorylated asyn (a marker of LP) and markers of MG derived NI, namely, IBA1 (pan MG marker), MHCII (antigen presentation), and CD68 (phagocytosis) by immunohistochemistry. We used QuPath v0.5.1 to measure percent area occupied (%AO) of these markers in each hippocampal subfield (Subiculum, CA1, 2, 3, 4, and DG). %AO was log2 transformed to obtain a normal distribution and Pearson correlation compared expression of MG markers with LP. Finally, we used linear-mixed effects (LME) models with subfield as a fixed factor to compare the %AO for each stain across subfields within patient groups while co-varying for age and sex.

Results: LME models for each MG marker consistently found CA2 with the highest density of MG markers and LP (B=-.146- -.41479, p<0.01). LP correlated with activated MG markers (MHCII: R=.27, p<0.05; CD68: R=0.27, p<0.05) but not the pan-MG marker (IBA1 P=0.17, p>0.05) in the CA2. Male sex was associated with increased CD68 %AO (B=0.246, p<0.01).

Conclusion: LP correlated with NI only in the CA2 indicating that NI may contribute to CA2 susceptibility to LP, and male sex may modulate this relationship. This study improves our understanding of NI development within the subregions of the hippocampus.

To cite this abstract in AMA style:

E. Luna, K. Cousins, S. Emrani, K. Luk, V. Lee, E. Lee, D. Weintraub, S. Xie, A. Chen-Plotkin, F. Bennett, D. Irwin. Lewy Pathology correlates with neuroinflammation in the hippocampus of Synucleinopathy patients in a subregion specific manner [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/lewy-pathology-correlates-with-neuroinflammation-in-the-hippocampus-of-synucleinopathy-patients-in-a-subregion-specific-manner/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/lewy-pathology-correlates-with-neuroinflammation-in-the-hippocampus-of-synucleinopathy-patients-in-a-subregion-specific-manner/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley